CVRX

CVRx, Inc.

NasdaqAdd to watchlist

Healthcare · Medical Devices

$3.04

+$0.04+1.33%

Delayed · 2026-09-18T20:00:00.000Z · marketstack

6 of 10 open-market sales on file ran under a pre-arranged trading plan ($130K), 4 did not. Who, and when

Aug 24, 2026$3.04

−$0.11−3.49%over 1M

Session

Day range83% of range

$2.92$3.07

Fundamentals

Visualize fundamentals and more

Market cap: 80.61M
P/E ratio: -

Revenue grew +10.45% in FY2025, in line with its sector. The median across Healthcare companies this platform tracks is +8.87%.

Risk factors, year on year

Item 1AFeb 2026 10-KFeb 2025

added: 26
dropped: 27
re-drafted: 29

Out of 225 passages in this year’s Item 1A.

New this year

In addition, physicians typically need to perform several procedures to become comfortable using Barostim. If a physician experiences difficulties during an initial procedure or otherwise, that physician may be less likely

52 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add

What it says it is exposed to

From Item 1A of its most recent 10-K, filed February 2026.

FDA approval
Litigation
Product recalls
Currency moves
Reimbursement
Tax
Export controls
Key people

And 16 more.

FDA approval
We also face fierce competition, particularly in this tight labor market, in recruiting and retaining qualified sales, scientific and management personnel, establishing clinical trial sites and enrolling patients in clinical studies. If our competitors are …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Recent activity

Aug 13 Binkowski Brent bought 26,223 shares Insider trading Form 4 CHIEF OPERATING OFFICER, about $76k
Aug 11 Leadership change Company filing 8-K
Aug 6 Results announcement Company filing 8-K

18 more events are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Updated Sep 18, 2026 · the last close

CVRx, Inc. investor relations

What CVRX has filed with the SEC. This is not CVRx, Inc.’s own investor relations site: these filings are the primary source that site publishes from.

Companies like CVRx, Inc.

Also filed under Medical Devices, ranked by how closely they sit beside CVRX.

BSXBoston Scientific Corp.compare with CVRX
MDTMedtronic plccompare with CVRX
ABTAbbott Laboratories

EWEdwards Lifesciences Corpcompare with CVRX

Ask about CVRx, Inc.

The assistant answers from what CVRX has actually filed: 6 annual reports filed with the SEC, 29 Form 4 filings from the last year and 2 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Press one and the answer appears right here on the page, from CVRX's filings and figures. One a day without an account; a free account has its own, and no card.

See how much of CVRx, Inc. each of these investors holds, and every quarter they moved.

Ten seconds. No card. Nothing to cancel.

No card, no broker connection.

Continue with Google

What an account lets you do with CVRx, Inc.

Be told the moment a CVRX insider trades
Put CVRx, Inc. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
CVRx, Inc.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about CVRx, Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free account See what the paid plans add

Free, no card, and it does not expire.

Recent activity

Aug 13 Binkowski Brent bought 26,223 shares Insider trading Form 4 CHIEF OPERATING OFFICER, about $76k
Aug 11 Leadership change Company filing 8-K
Aug 6 Results announcement Company filing 8-K

18 more events are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

What it says it is exposed to

From Item 1A of its most recent 10-K, filed February 2026.

FDA approval
Litigation
Product recalls
Currency moves
Reimbursement
Tax
Export controls
Key people

And 16 more.

FDA approval
We also face fierce competition, particularly in this tight labor market, in recruiting and retaining qualified sales, scientific and management personnel, establishing clinical trial sites and enrolling patients in clinical studies. If our competitors are …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Risk factors, year on year

Item 1AFeb 2026 10-KFeb 2025

added: 26
dropped: 27
re-drafted: 29

Out of 225 passages in this year’s Item 1A.

New this year

In addition, physicians typically need to perform several procedures to become comfortable using Barostim. If a physician experiences difficulties during an initial procedure or otherwise, that physician may be less likely

52 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add